Financials data is unavailable for this security.
View more
Year on year Humacyte Inc 's revenues fell -100.00% from 1.57m to 0.00. has fallen 825.83% from a loss of 11.97m to a larger loss of 110.78m.
| Gross margin | -- |
|---|---|
| Net profit margin | -- |
| Operating margin | -- |
| Return on assets | -91.17% |
|---|---|
| Return on equity | -850.81% |
| Return on investment | -100.75% |
More ▼
Cash flow in USDView more
In 2023, cash reserves at Humacyte Inc fell by 68.97m. Cash Flow from Financing totalled 4.51m or -- of revenues. In addition the company used 73.31m for operations while cash used for investing totalled 173.00k.
| Cash flow per share | -1.22 |
|---|---|
| Price/Cash flow per share | -- |
| Book value per share | -0.237 |
|---|---|
| Tangible book value per share | -0.237 |
More ▼
Balance sheet in USDView more
| Current ratio | 5.41 |
|---|---|
| Quick ratio | -- |
| Total debt/total equity | -- |
|---|---|
| Total debt/total capital | -- |
More ▼
